|
- 2016
鼠神经生长因子联合维生素D、甲钴胺治疗糖尿病周围神经病变的临床观察
|
Abstract:
[1] | Davies M, Brophy S, Williams R, et al. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes[J]. Diabetes Care, 2006, 29(7):1518-1522. |
[2] | Van Acker K, Bouhassira D, De Bacquer D, et al. Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital out patients clinics[J]. Diabetes Metab, 2009, 35(3): 206-213. |
[3] | Shehab D, Al-Jarallah K, Mojiminiyi OA, et al. Does Vitamin D deficiency play a role in peripheral neuropathy in Type 2 diabetes?[J]. Diabet Med, 2012, 29(1): 43-49. |
[4] | Holick MF. Vitamin D deficiency[J]. N Engl J Med, 2007, 357(3): 266-281. |
[5] | Dey I, Midha N, Singh G, et al. Diabetic Schwann cells suffer from nerve growth factor and neurotrophin-3 underproduction and poor associability with axons[J]. Glia, 2013, 61(12): 1990-1999. |
[6] | Tosaki T, Kamiya H, Yasuda Y, et al. Reduced NGF secretion by Schwann cells under the high glucose condition decreases neurite outgrowth of DRG neurons[J]. Exp Neurol, 2008, 213(2): 381-387. |
[7] | Lu B, Yang Z, Wang M, et al. High prevalence of diabetic neuropathy in population-based patients diagnosed with type 2 diabetes in the Shanghai downtown[J]. Diabetes Res Clin Pract, 2010, 88(3): 289-294. |
[8] | Pilz S, Kienreich K, Rutters F, et al. Role of vitamin D in the development of insulin resistance and type 2 diabetes[J]. Curr Diab Rep, 2013, 13(2): 261-270. |
[9] | Lee P, Chen R. Vitamin D as an analgesic for patients with type 2 diabetes and neuropathic pain[J]. Arch Intern Med, 2008, 168(7): 771-772. |
[10] | Tesfaye S, Selvarajah D. Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy[J]. Diabetes Metab Res Rev, 2012, 28(S1): 8-14. |
[11] | 李书林, 蒋晓江, 陈曼娥. 大鼠坐骨神经损伤后髓鞘碱性蛋白与神经功能的变化及神经生长因子的影响[J]. 中国临床康复, 2002, 6(6): 798-799. LI Shulin, JIANG Xiaojiang, CHEN Mane. Effects of NGF on the changes of MBP in nervous tissue and the neurological behavior following sciatic nerves injury in rats[J]. Modern Rehabilitation, 2002, 6(6): 768-799. |
[12] | Kim HC, Cho YJ, Ahn CW, et al. Nerve growth factor and expression of its receptors in patients with diabetic neuropathy[J]. Diabet Med, 2009, 26(12): 1228-1234. |
[13] | Apfel SC, Kessler JA, Adornato BT, et al. Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. NGF Study Group[J]. Neurology, 1998, 51(3): 695-702. |
[14] | Zerwekh JE. Blood biomarkers of vitamin D status[J]. Am J Clin Nutr, 2008, 87(4): S1087-S1091. |
[15] | Cheng HT, Dauch JR, Hayes JM, et al. Nerve growth factor mediates mechanical allodynia in a mouse model of type 2 diabetes[J]. Neuropathol Exp Neurol, 2009, 68(11): 1229-1243. |
[16] | Hellweg R, Raivich G, Hartung HD, et al. Axonal transport of endogenous nerve growth factor(NGF)and NGF receptor in experimental diabetic neuropathy[J]. Exp Neurol, 1994, 130(1): 24-30. |
[17] | Bell DS. Reversal of the symptoms of diabetic neuropathy through correction of vitamin D deficiency in a type 1 diabetic patient[J]. Case Rep Endocrinol, 2012: 165056. doi:10.1155/2012/165056. |
[18] | Cornet A, Baudet C, Neveu I, et al. 1,25-Dihydroxyvitamin D3 regulates the expression of VDR and NGF gene in Schwann cells in vitro[J]. J Neurosci Res, 1998, 53(6): 742-746. |
[19] | Brown J, Bianco I, McGrath JJ, et al. 1,25-dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons[J]. Neurosci Lett, 2003, 343(2): 139-143. |
[20] | Soderstrom LH, Johnson SP, Diaz VA, et al. Association between vitamin D and diabetic neuropathy in a nationally representative sample: results from 2001-2004 NHANES[J]. Diabet Med, 2012, 29(1): 50-55. |
[21] | Rask CA. Biological actions of nerve growth factor in the peripheral nervoussystem[J]. Eur Neurol, 1999, 41(Suppl 1):14-19. |
[22] | Shehab D, Al-Jarallah K, Abdella N, et al. Prospective evaluation of the effect of short-term oral vitamin D supplementation on peripheral neuropathy in type 2 diabetes mellitus[J]. Med Princ Pract, 2015, 24(3): 250-256. |
[23] | Rukwied R, Mayer A, Kluschina O, et al. NGF induces non-inflammatory localized and lasting mechanical and thermal hypersensitivity in human skin[J]. Pain, 2010, 148(3): 407-413. |